Skip to main content

Gate — Portfolio, Page 23

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

1,203
Companies
$770.1M
Total invested
$8.3M
Avg. check
44
Industries
Biotechnology 7Health Care 6Medical 5Therapeutics 5Artificial Intelligence (AI) 5Pharmaceutical 4+38 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 529–552 of 1,203
EFEX
February 2026

EFEX offers international payments, invoicing, reconciliation and collection to facilitate international trade for businesses.

Financial Services · Menlo Park$10.6M Seed
Ten63 Therapeutics
February 2026

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.

Biotechnology · DurhamGrant
Adronite
February 2026

Adronite is a software development company currently operating in stealth mode.

Computer · Seattle$5.0M Series A
Axmed
February 2026

Axmed is a medical marketplace that offers access to medicines for healthcare providers through business and technology solutions.

Health Care · Basel$6.0M Grant
Tozaro
February 2026

Tozaro is a biotechnology company that develops synthetic affinity reagents for cell and gene therapy.

Biotechnology · Bedford$8.2M Series Unknown
Chemify
February 2026

Chemify integrates chemistry with robotics and machine learning to digitize the process of molecule creation.

Artificial Intelligence (AI) · GlasgowSeries Unknown
Centivax
February 2026

Centivax is a biotechnology company that develops vaccines and therapeutic antibodies targeting infectious diseases and venomous threats.

Biotechnology · South San Francisco$26.0M Grant
Trener Robotics
February 2026

Trener Robotics is a robot software company that uses the inference power to detect and execute tasks based on natural language commands

Artificial Intelligence (AI) · San Francisco$32.0M Series A
Euclid Protocol
February 2026

Euclid is a decentralized cross-chain liquidity infrastructure that any application across the blockchain can tap source of liquidity.

Blockchain · Dubai$3.5M Seed
Fieldguide
February 2026

Agentic AI for Audit and Advisory.

Accounting · San Francisco$75.0M Series C
Learnvia
January 2026

Learnvia combines courses, homework, quizzes, a discussion forum, and an artificial intelligence instructor.

Higher Education$55.0M Grant
Heritable Agriculture
January 2026

Heritable Agriculture focuses on improving plant breeding and biotechnology to strengthen the world's food and agricultural systems.

Agriculture · Mountain View$5.0M Grant
1st Biotherapeutics
January 2026

1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.

Pharmaceutical · Seongnam$21.9M Series D
Game Actor
January 2026

Game Actor is a social media platform where gamers can show statistics, connect with others, and share gaming experiences

Gamification · Sariyer$400K Seed
Cork Protocol
January 2026

Cork offers collateralized swaps against any pegged asset.

Decentralized Finance (DeFi) · New York$5.5M Seed
Zelira Hope 1
January 2026

Zelira Hope 1 is owned by Zelira Therapeutics, that focuses on advancing the company's lead cannabinoid-based drug candidate.

—$33.0M Series A
Eyam Health
January 2026

Eyam Health concentrates on the investigation and creation of vaccines for defending against infectious diseases.

Biopharma · Surrey$327K Grant
SkyFi®
January 2026

SkyFi® is an earth intelligence platform that provides satellite imagery and analytics to help interpret and analyze planetary data.

Aerospace · Austin$12.7M Series A
AiderX
January 2026

AiderX is a technology startup that creates AI assistants for everyone.

Advertising · Seongnam$6.8M Seed
Replicate Bioscience
January 2026

Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.

Biotechnology · San Diego$7.0M Grant
Wedge
January 2026

Competitive Wedge offers a one-way recorded video interview built for the demands of modern recruiting.

Human Resources · Grand Rapids$1.5M Series Unknown
Just - Evotec Biologics
January 2026

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Biopharma · SeattleGrant
STRM.BIO
January 2026

STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.

Biotechnology · Cambridge$8.0M Seed
vitrealab
January 2026

vitrealab unlocks Augmented Reality for everyday use, with its proprietary laser matrix photonic integrated circuit.

Vienna$11.0M Series A

Where Gate invests

Biotechnology7
Health Care6
Medical5
Therapeutics5
Artificial Intelligence (AI)5
Pharmaceutical4

About Gate's portfolio

How many companies has Gate invested in?▸

Gate has invested in 1,203 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Gate invest in?▸

Gate's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Artificial Intelligence (AI). The firm invests across 44 different industry categories.

What is Gate's largest investment?▸

Among tracked funding rounds, Fieldguide received $75.0M in a Series C round. Gate's total known invested capital is $770.1M.

What is the average investment size for Gate?▸

Gate's average investment size is $8.3M across its portfolio of 1,203 companies.

What are Gate's most recent investments?▸

Recent Gate portfolio additions include EFEX, Ten63 Therapeutics, Adronite, Axmed, Tozaro. These companies were founded in 2020 or later.

Reach the founders behind these 1,203 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →